Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 33 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9808505

    Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  2. US 9809588

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  3. US 9808486

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  4. US 9801962

    Radioactive nanoparticles and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  5. US 9801944

    Lipocationic polymers and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  6. US 9801863

    Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  7. US 9795673

    Treating macular degeneration using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  8. US 9790274

    Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  9. US 9789096

    Methods and compositions for selective and targeted cancer therapy

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  10. US 9789131

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  11. US 9790495

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  12. US 9789116

    Compositions and methods of modulating short-chain dehydrogenase activity

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  13. US 9790233

    Compositions and methods of modulating 15-PGDH activity

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  14. US 9783550

    Highly potent inhibitors of porcupine

    The Board of Regents of the University of Texas System · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  15. US 9770500

    S-nitrosylation of glucosylating toxins and uses therefor

    The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  16. US 9770504

    Generating peptoid vaccines

    The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  17. US 9765099

    STAT6 inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  18. US 9757379

    Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)

    The Board of Regents of the University of Texas System · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  19. US 9750849

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  20. US 9751970

    Block copolymer and micelle compositions and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  21. US 9744142

    Formulations of volatile anesthetics and methods of use for reducing inflammation

    The Board of Regents of the University of Texas System · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  22. US 9737512

    Methods and compositions for treating chronic pain

    The Board of Regents of the University of Texas System · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  23. US 9731023

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  24. US 9730894

    Stabilized HME composition with small drug particles

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted